Biden administration aims to crack down on inadequate insurance for mental health care

Biden administration aims to crack down on inadequate insurance for mental health care


A young woman sits on a couch with her therapist.

Sdi Productions | E+ | Getty Images

The Biden administration plans to crack down on health insurance plans that discriminate against people who need mental health care and substance abuse treatments.

A proposed rule published Tuesday by the Health and Human Services, Labor and Treasury departments aims to push health insurers to comply with the Mental Health Parity and Addiction Equity Act.

That law, which was passed in 2008, requires insurance plans that cover mental health care and substance abuse treatments to offer the same level of coverage for these services as they do for other illnesses.

White House domestic policy advisor Neera Tanden told reporters in a call Monday that too many insurers are evading the law and making it difficult for patients to access mental health care.

Insurance plans often do not provide enough therapists in network, which forces patients to seek care out of network and pay more. Patients also often have to get permission from their insurer to seek treatment or have their claims denied leaving them with the bill.

“This has meant millions of people who have insurance are paying out of pocket when they shouldn’t have to,” Tanden said.

More than one in five adults in the U.S., or 58 million people, live with a mental illness, according to the National Institute of Mental Health.

CNBC Health & Science

Read CNBC’s latest health coverage:

The proposed rule would require insurance plans to evaluate how their coverage policies impact patients’ access to mental health and substance abuse treatments, Tanden said.

Insurers would be required to take action if they are not in compliance with the law, she said. This could include adding more therapists to the insurance network if patients are seeking care out of network too often, Tanden said.

The proposed rule will undergo a 60-day public comment period before it is finalized.

A survey published in July of nearly 2,800 patients found that people with insurance face more challenges accessing mental health services than other types of medical care.

Nearly 40% of people enrolled in insurance through their employer had to seek more costly mental health care or substance abuse treatment out of network, according to the survey conducted by the research institute NORC. By comparison, 15% of people seeking physical health care went out of network.

More than 50% of patients reported that their insurance denied coverage three or more times for mental health or substance abuse services, compared to 33% who reported the same for physical health care.

And nearly 60% of those surveyed who sought mental health care or substance abuse treatment did not receive any care in at least one instance.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More